LRRC42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.368800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.711000E-01
Normal-vs-Stage2
2.269600E-01
Normal-vs-Stage3
6.963400E-01
Normal-vs-Stage4
1.480180E-01
Stage1-vs-Stage2
6.359200E-01
Stage1-vs-Stage3
7.500600E-01
Stage1-vs-Stage4
3.787800E-01
Stage2-vs-Stage3
4.259600E-01
Stage2-vs-Stage4
5.138600E-01
Stage3-vs-Stage4
2.740800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.525400E-01
Normal-vs-AfricanAmerican
3.400400E-01
Normal-vs-Asian
2.179400E-01
Caucasian-vs-AfricanAmerican
7.947800E-01
Caucasian-vs-Asian
8.315200E-01
AfricanAmerican-vs-Asian
9.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.743800E-01
Normal-vs-Female
2.146800E-01
Male-vs-Female
2.507800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.748200E-01
Normal-vs-Age(41-60Yrs)
5.837600E-02
Normal-vs-Age(61-80Yrs)
3.664200E-01
Normal-vs-Age(81-100Yrs)
4.037400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.545800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.784200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.859600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.839540E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.914200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.481600E-01
Normal-vs-Daily Drinker
2.423600E-01
Normal-vs-Weekly Drinker
3.150800E-01
Normal-vs-Occasional Drinker
6.202000E-02
Normal-vs-Social Drinker
3.093200E-01
Non Drinker-vs-Daily Drinker
5.368800E-01
Non Drinker-vs-Weekly Drinker
6.149800E-01
Non Drinker-vs-Occasional Drinker
1.421800E-01
Non Drinker-vs-Social Drinker
7.248400E-01
Daily Drinker-vs-Weekly Drinker
2.224000E-01
Daily Drinker-vs-Occasional Drinker
3.526000E-01
Daily Drinker-vs-Social Drinker
3.302800E-01
Weekly Drinker-vs-Occasional Drinker
2.598100E-02
Weekly Drinker-vs-Social Drinker
8.685200E-01
Occasional Drinker-vs-Social Drinker
3.733800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.390600E-01
Normal-vs-Grade 2
1.611240E-01
Normal-vs-Grade 3
2.392800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.778250E-04
Grade 1-vs-Grade 3
1.523320E-03
Grade 1-vs-Grade 4
8.390600E-01
Grade 2-vs-Grade 3
5.788200E-01
Grade 2-vs-Grade 4
1.611240E-01
Grade 3-vs-Grade 4
2.392800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.625600E-01
Normal-vs-NonDiabetic
1.817390E-01
Diabetic-vs-NonDiabetic
3.539600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.274100E-02
Normal-vs-NoPancreatitis
2.609000E-01
Pancreatitis-vs-NoPancreatitis
8.766200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.581400E-01
Normal-vs-N1
2.296600E-01
N0-vs-N1
7.918400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.139600E-02
Normal-vs-TP53-NonMutant
4.265600E-01
TP53-Mutant-vs-TP53-NonMutant
5.957300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
